Source: International Congress 2017 – A novel approach to lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
T. Blum (Berlin, Germany). Latest treatable molecular alterations in lung cancer. International Congress 2017 – A novel approach to lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Pathology and molecular biology of lung cancer Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer Year: 2006 Challenges in molecular testing in lung cancer patients with advanced disease Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management Year: 2016 Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002 The role of molecular pathology in diagnosis and treatment of lung cancer Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases Year: 2007 Molecular abnormalities and histopathology in lung cancer Source: ERS Research Seminar Year: 2015 Accompanying diseases in lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 127s Year: 2006 Evolution in the pathological study of lung cancer Source: Virtual Congress 2020 – Management issues in thoracic oncology Year: 2020 Complexity of diagnostics of complicated lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004 Multi-omic molecular profiling of lung cancer in COPD Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017 Year: 2018 Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Pathogenesis of lung cancer signalling pathways: roadmap for therapies Source: Eur Respir J 2009; 33: 1485-1497 Year: 2009 BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers Source: Eur Respir J 2015; 45: 1403-1414 Year: 2015 Cytological diagnostics of lung cancer: our experience Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005 Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006 Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015